TNYA Insider Trading Activity and SEC Form 4 Filings
TNYA insider trading summary
Over the past 12 months, insiders at Tenaya Therapeutics, Inc. (TNYA) reported 119 sales worth $47.5M by 11 insiders and no open-market purchases on SEC Form 4. Net insider selling was $47.5M.
Latest TNYA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 17, 2026 | Whittemore Tingley | Chief Medical Officer | Sell | $1K (1,637 @ $0.71) |
| Aug 17, 2026 | Faraz Ali | Chief Executive Officer | Sell | $3K (3,969 @ $0.71) |
| Aug 17, 2026 | Faraz Ali | Chief Executive Officer | Sell | $5K (7,406 @ $0.71) |
| Aug 17, 2026 | Whittemore Tingley | Chief Medical Officer | Sell | $1K (1,637 @ $0.71) |
| Aug 17, 2026 | Whittemore Tingley | Chief Medical Officer | Sell | $2K (2,279 @ $0.71) |
| Aug 17, 2026 | Faraz Ali | Chief Executive Officer | Sell | $4K (5,837 @ $0.71) |
| Aug 17, 2026 | Whittemore Tingley | Chief Medical Officer | Sell | $1K (1,871 @ $0.71) |
| Aug 17, 2026 | Faraz Ali | Chief Executive Officer | Sell | $4K (5,020 @ $0.71) |
| May 18, 2026 | Whittemore Tingley | Chief Medical Officer | Sell | $2K (3,121 @ $0.79) |
| May 18, 2026 | Faraz Ali | Chief Executive Officer | Sell | $3K (3,390 @ $0.79) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.